Ryan joined NEA in 1996 as a Principal, became a Partner in 2002, and a General Partner in 2004. He specializes in healthcare investments in the specialty pharma, medical device and healthcare services sectors. Present board memberships include BENU, Concentric Medical, Esprit Pharma, ExploraMed II, ForHealth Technologies, FoxHollow Technologies (NASDAQ: FOXH), Intrinsic Therapeutics, PatientKeeper, Provation Medical, Spine Wave, Viacor and Windward Medical. Past board memberships include ESP Pharma (acquired by Protein Design Labs, Inc.) and Proxima Therapeutics (acquired by Cytyc Corporation), and Ryan co-led NEA's investment in Xcel Pharmaceuticals (acquired by Valeant Pharmaceuticals, Inc.). Prior to joining NEA, Ryan was with the Health Care Investment Banking Group of Alex. Brown & Sons in San Francisco where he focused primarily on the medical device, biopharmaceutical and healthcare services areas. Previously, he worked in the San Francisco office of Arthur Andersen & Co. Ryan received a BA from Stanford University.